Evotec and X-Biotix: Discovery of Novel UDP-N-Acetylglucosamine Acyltranferase (LPxA) Inhibitors With Activity Against Pseudomonas Aeruginosa
- 24 March 2022
- Resource Type: Anti-Infectives, Structural Biology & Protein Science, Videos & Webinars
Watch the webinar to learn more about exciting new developments in predictive toxicology!
About the Webinar
In this webinar, John Barker, SVP Global Head of Protein Sciences discusses bacterial infections and global health within anti-infectives. John gave this talk at the Oxford Global Discovery UK event in October 2021.
About the Speaker
 |
John Barker, PhD FRSB Senior Vice President, Global Head of Protein Sciences | Evotec Currently responsible for more than 150 scientists across four sites, Princeton NJ, Abingdon UK, Toulouse and Hamburg. Team delivering Protein Production, Structural Biology and Cellular Sciences both internally and to Evotec’s partnerships. Over the past 18 years built from the ground up the current Evotec structural biology unit, now with more than 30 PhD scientists, one of the largest units in industry. Supporter of UK industry as the Industrial Life Science representative on the Diamond Scientific Advisory Board. John has worked on more than 40 collaborations across a range of drug discovery projects including multiple structure and fragment guided programmes in all therapeutic areas. |